Beijing Science Sun Pharmaceutical Co Ltd Working Capital to Net Assets Ratio
Beijing Science Sun Pharmaceutical Co Ltd working capital to net assets ratio. Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Working Capital to Net Assets ratio of 47.0% as of June 2026. Working capital of CN¥1.52 Billion (current assets of CN¥1.60 Billion minus current liabilities of CN¥75.14 Million) is measured against net assets of CN¥3.23 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Beijing Science Sun Pharmaceutical Co Lt's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Beijing Science Sun Pharmaceutical Co Ltd (2011–2025)
Working capital to net assets ratio of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2025. This chart shows how Beijing Science Sun Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 47.0%, reflecting working capital of CN¥1.52 Billion against net assets of CN¥3.23 Billion CNY. See 300485 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Beijing Science Sun Pharmaceutical Co Ltd Working Capital to Net Assets Ratio by Year (2011–2025)
Beijing Science Sun Pharmaceutical Co Ltd working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Beijing Science Sun Pharmaceutical Co Lt total assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 47.0% | CN¥1.60 Billion | CN¥3.39 Billion | CN¥1.69 Billion | CN¥92.30 Million | ▼ -1.1 pp |
| 2024 | 48.1% | CN¥1.63 Billion | CN¥3.39 Billion | CN¥1.71 Billion | CN¥82.05 Million | ▲ +10.6 pp |
| 2023 | 37.5% | CN¥1.30 Billion | CN¥3.47 Billion | CN¥1.35 Billion | CN¥51.45 Million | ▲ +1.0 pp |
| 2022 | 36.5% | CN¥1.25 Billion | CN¥3.41 Billion | CN¥1.32 Billion | CN¥74.94 Million | ▼ -7.4 pp |
| 2021 | 43.9% | CN¥1.44 Billion | CN¥3.28 Billion | CN¥1.53 Billion | CN¥88.46 Million | ▼ -3.4 pp |
| 2020 | 47.3% | CN¥1.35 Billion | CN¥2.85 Billion | CN¥1.48 Billion | CN¥135.70 Million | ▼ -9.6 pp |
| 2019 | 56.9% | CN¥1.54 Billion | CN¥2.71 Billion | CN¥1.63 Billion | CN¥88.06 Million | ▼ -5.7 pp |
| 2018 | 62.6% | CN¥1.60 Billion | CN¥2.56 Billion | CN¥1.79 Billion | CN¥195.94 Million | ▼ -5.9 pp |
| 2017 | 68.5% | CN¥1.59 Billion | CN¥2.32 Billion | CN¥1.72 Billion | CN¥133.64 Million | ▼ -4.8 pp |
| 2016 | 73.3% | CN¥1.54 Billion | CN¥2.10 Billion | CN¥1.66 Billion | CN¥117.88 Million | ▼ -11.5 pp |
| 2015 | 84.8% | CN¥1.60 Billion | CN¥1.88 Billion | CN¥1.66 Billion | CN¥60.78 Million | ▲ +10.4 pp |
| 2014 | 74.4% | CN¥480.78 Million | CN¥646.64 Million | CN¥550.80 Million | CN¥70.02 Million | ▲ +10.1 pp |
| 2013 | 64.3% | CN¥317.25 Million | CN¥493.71 Million | CN¥364.58 Million | CN¥47.33 Million | ▲ +10.8 pp |
| 2012 | 53.5% | CN¥192.45 Million | CN¥359.96 Million | CN¥227.62 Million | CN¥35.18 Million | ▼ -5.9 pp |
| 2011 | 59.3% | CN¥146.78 Million | CN¥247.37 Million | CN¥179.17 Million | CN¥32.39 Million | — |